Application for a clinical RMD research methodology was approved by the EULAR research Committee on the 12th of MARCH 2024, for a total funding of 50’000 Euros.
The EULAR grant for FIARVASC
You may also like
The FAIRVASC consortium will meet for a Plenary meeting in the Conference Center at the Faculty of Medicine in Kraków, Poland on […]
Interview with Kris McGLinn about the role and tasks of QIT in FAIRVASC project has been published
Within FAIRVASC Workpackage 2 (WP2) will capture the legal and ethical environment of each registry, patient perspectives on data sharing and re-use, […]
Interview with Prof. Augusto Vaglio about the role and tasks of QIT in FAIRVASC project has been published.